Skip to search formSkip to main contentSkip to account menu

cefroxadine

Known as: 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methoxy-8-oxo-, (6R-(6 alpha,7 beta(R*)))-, 7-(D-2-amino-2-(1,4-cyclohexadienyl)acetamido)-3-methoxy-3-cephem-4-carboxylic acid, cefroxadin 
A semisynthetic first-generation cephalosporin with antibacterial activity. Cefroxadine binds to and inactivates penicillin-binding proteins (PBPs… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Effects of angiotensin-converting enzyme (ACE) inhibitors, captopril, enalapril maleate and quinapril, on the uptake of… 
Highly Cited
1983
Highly Cited
1983
The absorption mechanism of aminocephalosporins was investigated in rat small intestine. Cephalosporins chosen in this study were… 
1982
1982
The pharmacokinetics of cefroxadin have been studied after the administration of single oral and intravenous doses to healthy… 
1982
1982
A pharmacokinetic model has been developed, by means of which all possible time courses of the concentrations of antibiotics in… 
1982
1982
It was shown that the intestinal absorption clearance of D2O (CLD2O) could be a more appropriate index to study the solvent drag… 
1980
1980
Oral doses of 125, 250, and 500 mg of a new cephalosporin, CGP 9000 (7 beta-[D-2-amino-2-(1,4-cyclohexadienyl)-acetamido]-3… 
1980
1980
Cefroxadine (GCP-9000; CXD), 7 beta[D-2-amino-2-(1,4-cyclohexadienyl)-acetamido]-3-methoxy-ceph-3-em-carboxylic acid, is a new…